Ropivacaine Hydrochloride Injection shortage
Current 49 presentations · 5 manufacturers · first FDA posting 2018-03-23 · last update 2026-10-15
Manufacturers: Caplin Steriles, Ltd., Eugia US LLC, Fresenius Kabi USA, LLC, InfoRLife SA, Somerset Therapeutics, LLC
Stated reasons (per FDA): Delay in shipping of the drug; Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10) | Caplin Steriles, Ltd. | Current Limited Availability |
Other | Check wholesalers for inventory; Marketed by Baxter | Posted 12/22/2020 Updated 06/10/2026 |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Baxter | Posted 12/22/2020 Updated 06/10/2026 |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10) | Caplin Steriles, Ltd. | Current Limited Availability |
Other | Limited supply; Check wholesalers for inventory; Marketed by Baxter | Posted 12/22/2020 Updated 06/10/2026 |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10) | Caplin Steriles, Ltd. | Current Available |
— | Check wholesalers for inventory; Marketed by Baxter | Posted 12/22/2020 Updated 06/10/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/02/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesaler for inventory | Posted 03/23/2018 Updated 10/06/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted 03/23/2018 Updated 10/15/2026 |
| Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Fresenius Kabi USA, LLC | Current Available |
— | Posted 03/23/2018 Updated 10/15/2026 | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82) | InfoRLife SA | Current Available |
— | Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87) | InfoRLife SA | Current Available |
— | Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66) | InfoRLife SA | Current Available |
— | Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67) | InfoRLife SA | Current Unavailable |
Other | Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82) | InfoRLife SA | Current Available |
— | Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87) | InfoRLife SA | Current Available |
— | Marketed by Sagent Pharmaceuticals | Posted 03/27/2018 Updated 10/06/2026 |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 | |
| Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25) | Somerset Therapeutics, LLC | Current Available |
— | Posted 03/23/2018 Updated 09/11/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)